| Institutions |
Authors |
Share |
|
Vivace Therapeutics, Inc., United States of America (USA)
|
5.000000
|
0.28 |
|
The University of Texas MD Anderson Cancer Center, United States of America (USA)
|
2.000000
|
0.11 |
|
Massachusetts General Hospital (MGH), United States of America (USA)
|
1.000000
|
0.06 |
|
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
|
1.000000
|
0.06 |
|
Westchester Medical Center (WMC), United States of America (USA)
|
1.000000
|
0.06 |
|
University of Minnesota (UMN), United States of America (USA)
|
1.000000
|
0.06 |
|
Peter MacCallum Cancer Centre (Peter Mac), Australia
|
1.000000
|
0.06 |
|
Monash Medical Centre (MMC), Australia
|
1.000000
|
0.06 |
|
NEXT Oncology, United States of America (USA)
|
1.000000
|
0.06 |
|
Toxicology Solutions, United States of America (USA)
|
1.000000
|
0.06 |
|
The University of Chicago (UChicago), United States of America (USA)
|
1.000000
|
0.06 |
|
Brigham and Women's Hospital (BWH), United States of America (USA)
|
0.500000
|
0.03 |
|
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
|
0.500000
|
0.03 |
|
The University of Western Australia (UWA), Australia
|
0.500000
|
0.03 |
|
Linear Clinical Research, Australia
|
0.500000
|
0.03 |
